2024, Number 7
<< Back Next >>
Med Crit 2024; 38 (7)
Evaluation of cardiac power as a predictor of outcome in patients with sepsis
González MVM, Aguirre SJS, Martínez DBA, Gaytán GCJ
Language: Spanish
References: 10
Page: 581-583
PDF size: 240.11 Kb.
ABSTRACT
Introduction: sepsis is a severe clinical condition that leads to potentially fatal organ failure due to an inadequate host response to infection. In the field of critical care, the impact of sepsis on the cardiovascular system has been extensively studied, highlighting the importance of cardiac power (CP) as a key predictor of clinical outcomes in critically ill patients.
Objective: to evaluate cardiac power as a predictive factor for clinical evolution in sepsis patients admitted to the intensive care unit (ICU) of ABC Medical Center.
Material and methods: a prospective, observational, and longitudinal study was conducted on a population of 23 adult patients diagnosed with sepsis. Patients were monitored from ICU admission, recording key hemodynamic variables, including cardiac power.
Results: a cardiac power below 0.6 W is significantly associated with higher mortality and prolonged ICU stay.
Conclusion: these findings underscore the importance of early monitoring of cardiac power to identify high-risk patients and adjust therapeutic strategies accordingly.
REFERENCES
Ismail MT, Elbaih AH. Pathophysiology and management of different types of shock. NMJ. 2017;6(1):14-39.
Sakka SG. Hemodynamic monitoring in the critically ill patient - current status and perspective. Front Med (Lausanne). 2015;2:44.
Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368-1377.
Huygh J, Peeters Y, Bernards J, Malbrain ML. Hemodynamic monitoring in the critically ill: an overview of current cardiac output monitoring methods. F1000Res. 2016;5:1-9.
Fincke R, Hochman JS, Lowe AM, Menon V, Slater JN, Webb JG, et al. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the Shock Trial Registry. J Am Coll Cardiol. 2004;44:341-348.
Arnold RC, Shapiro NI, Jones AE, et al. Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis. Shock. 2009;32:35-39.
Charpentier J, Luyt CE, Fulla Y, et al. Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med. 2004;32:660-665.
Calvin JE, Driedger AA, Sibbald WJ. Assessment of myocardial function in human sepsis utilizing ECG gated cardiac scintigraphy. Chest. 1981;80:579-586.
Rudiger A, Singer M. Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med. 2007;35:1599-1608.
Lupi HE, Chuquiure VE, González PH, et al. "El poder cardiaco" un instrumento del pasado, posiblemente una herramienta moderna en la valoración clínica, terapéutica y pronóstica del choque cardiogénico por síndrome isquémico coronario agudo. Arch Cardiol Mex. 2006;76:95-108.